Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
BIAsp 30
(biphasic insulin aspart 30/70 biosimilar) /
Novo Nordisk
Welcome,
Profile
Billing
Logout
10 Diseases
7 Trials
7 Trials
222 News
«
1
2
3
4
||||||||||
BIAsp 30
(biphasic insulin aspart 30/70 biosimilar) /
Novo Nordisk
Trial completion:
HUCKEPACK2: Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids
(clinicaltrials.gov) - Sep 21, 2011
P4
, N=20, Completed,
Sponsor: Medical University of Graz
Recruiting --> Completed
|||||
|||||
BIAsp 30
(biphasic insulin aspart 30/70 biosimilar) /
Novo Nordisk
New P4 trial, Combination therapy:
SimpleMix: Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes
(clinicaltrials.gov) - Aug 31, 2011
P4
, N=348, Completed,
Sponsor: Novo Nordisk